Obesity after pediatric liver transplantation: Prevalence and risk factors

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 6, 2012, Pages 657-662

  Sundaram, Shikha S ^a,e   Alonso, Estella M ^b   Zeitler, Phil ^c   Yin, Wanron ^d   Anand, Ravinder ^d  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d EMMES CORPORATION   (United States)

^e Hepatology and Nutrition   (Canada)

Author keywords

Liver transplant; Obesity; Pediatric; Risk factors

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BILE DUCT ATRESIA; BODY MASS; CHILD; ETHNICITY; FEMALE; HEALTH SURVEY; HISPANIC; HUMAN; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 84870931773     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318266243c     Document Type: Article

References (18)

1. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120(Suppl 4): S164-92.
2. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
3. Canzanello VJ, Schwartz L, Taler SJ, et al. Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997;3:1-9.
4. Mor E, Facklam D, Hasse J, et al. Weight gain and lipid profile changes in liver transplant recipients: Long-term results of the American FK506 Multicenter Study. Transplant Proc 1995;27:1126.
5. Munoz SJ, Deems RO, Moritz MJ, et al. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991;23(1 Pt 2):1480-3.
6. Reuben A. Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity. Liver Transpl 2001;7(11 Suppl1):S13-21.
7. Stegall MD, Everson G, Schroter G, et al. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995;60:1057-60.
8. Skelton JA, Cook SR, Auinger P, et al. Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 2009;9:322-9.
9. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-50.
10. Everhart JE, Lombardero M, Lake JR, et al. Weight change and obesity after liver transplantation: Incidence and risk factors. Liver Transpl Surg 1998;4:285-96.
11. Neal DA, Gimson AE, Gibbs P, et al. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Liver Transpl 2001;7:533-9.
12. Richards J, Gunson B, Johnson J, et al. Weight gain and obesity after liver transplantation. Transpl Int 2005;18:461-6.
13. Singh GK, Kogan MD, Van Dyck PC, et al. Racial/ethnic, socioeconomic, and behavioral determinants of childhood and adolescent obesity in the United States: Analyzing independent and joint associations. Ann Epidemiol 2008;18:682-95.
14. Dick AA, Spitzer AL, Seifert CF, et al. Liver transplantation at the extremes of the body mass index. Liver Transpl 2009;15:968-77.
15. Dick AA, Perkins JD, Spitzer AL, et al. Impact of obesity on children undergoing liver transplantation. Liver Transpl 2010;16:1296-302.
16. Munoz SJ, Elgenaidi H. Cardiovascular risk factors after liver transplantation. Liver Transpl 2005;(11 Suppl 2):S52-6.
17. Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128(5 Pt 1):608-15.
18. Type 2 diabetes in children and adolescents. American Diabetes Association. Pediatrics 2000;105(3 Pt 1):671-80.